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Purpose: Because low-quality trials may lead to erroneous conclusions, quality assess-
ments are necessary. Thus, in this study, we scrutinized randomized controlled trials 
(RCTs) published in the Korean Journal of Urology (KJU) to assess their quantity and 
quality. 
Materials and Methods: Upon extracting RCTs from all articles published in the KJU 
from 1991 to 2010, assessments were made on the basis of the Jadad scale and the ad-
equacy of allocation concealment. The selections and assessments were performed in-
dependently by two researchers, and adjustment of the differences was done by a 
third-party researcher. In addition, the factors that may affect quality were analyzed. 
Results: A total of 3,516 original articles were searched and 28 RCTs were extracted. 
In the 1990s, RCTs constituted only 0.27% of the total original articles, but in the 2000s, 
RCTs constituted 1.34%. The mean total Jadad score increased from 1.6 points in the 
1990s to 1.65 points in the 2000s. However, the percentage of "good quality" trials also 
increased from 20% to 30.43%. As for adequate allocation concealment, one study was 
observed in the 2000s. The aspect most lacking was appropriate dropout and dou-
ble-blinding. Studies with medical interventions or funded or examined by institutional 
review boards tended to receive higher quality assessments. 
Conclusions: Although RCTs consistently increased in both quantity and quality, in 
future studies, researchers should continue to strive toward achieving adequate alloca-
tion concealment and appropriate double-blinding. In addition, researchers must be-
come more interested in receiving external funding and undergoing examination by 
institutional review boards.
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INTRODUCTION
The Korean Journal of Urology (KJU), which was created 
in 1960, became an entirely English-language journal in 
January 2010 [1]. In addition, after its registration in the 
Scopus and Excerpta Medica Database (EMBASE), the 
KJU was indexed in PubMed and PubMed Central (PMC) 
starting in May 2010, making it an international journal 
that people worldwide can search and freely download its 
full text [2]. As the status of the KJU has increased, more 
prospective clinical studies have been published, and 
randomized controlled trials (RCTs) have particularly in-
creased in various fields. Because RCTs can avoid bias, 
they are considered the most reliable method for assessing 
the effectiveness of therapeutic interventions. RCTs per-
formed incorrectly, however, may produce incorrect 
results. Therefore, quality assessment of the study should 
be performed before applying the results of the published 
study to patients.
The quality assessment of prospective clinical studies in-Korean J Urol 2011;52:642-646
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cludes three methods: individual markers, checklists, and 
scales [3]. In particular, the assessment standard has a 
specified form that can allow quantitative assessment and 
can be easily applied. Thus, it has the advantage of allowing 
easy comparison of studies. Among the items included in 
the assessment standard, in particular, three items re-
garding randomization, double-blinding, and dropout are 
directly associated with the minimization of bias. The 
Jadad quality assessment scale (Jadad scale) is a typical 
quality assessment tool comprising the aforementioned 
three items [4]. An additional individual index is the as-
sessment of the suitability of allocation concealment. 
Allocation concealment, which is a separate concept from 
randomization, which refers to the generation of the order, 
is described as a method that executes the randomized allo-
cation sequence generated [5]. When patients are assigned 
for therapeutic intervention, adequate allocation conceal-
ment is required to avoid selection bias [6].
In the present study, both quality assessment using the 
Jadad scale and assessment of the suitability of allocation 
concealment, which is an individual index, were conducted 
on RCTs published in the KJU to observe the qualitative 
growth of design and performance. Quality assessment 
items with particularly lower scores and factors that may 
affect the results of the assessment were investigated to 
provide useful information for further studies in the KJU. 
MATERIALS AND METHODS
1. Subjects
A total of 3,516 original articles published in the KJU over 
the past 20 years from 1991 (volume 32) to 2010 (volume 
51) were manually searched.  
2. Extraction of randomized controlled trials
Of the prospective studies published in the KJU, those that 
used terms such as ‘randomized’, ‘randomization’, and 
‘randomly’ in the methods session were separately ex-
tracted by two researchers. Differences in the results of the 
extraction were discussed and resolved via third-party 
arbitration.  
3. Quality assessment of the randomized controlled trials 
extracted
Quality assessment was conducted by using the Jadad 
scale, and the suitability of allocation concealment was as-
sessed as an individual index. The assessments were con-
ducted independently by two researchers, and the results 
were compared. Any differences in the results were re-
solved via third-party arbitration. 
1) Jadad scale: The Jadad scale assesses three items re-
garding the generation of randomization order, dou-
ble-blinding, and dropout [7]. The range of the total score 
is 0-5 points. If the total score was 3 points or higher, the 
study was assessed as being of high quality. If the total 
score was 2 points or lower, the study was assessed as being 
of low quality [8]. For studies in which it was impossible 
to perform double-blinding, the study was assessed as be-
ing of high quality if the total score was 2 points or higher 
[9]. As for the generation of randomization order and dou-
ble-blinding, if they were only mentioned without a de-
tailed description, one point was assigned to each item. If 
an appropriate method was described, one more point was 
added. Meanwhile, if the described method was in-
appropriate, one point was deducted. Appropriate descrip-
tions of the generation of randomization order included 
“table of random sampling numbers” and “computer aided 
generation,” whereas inappropriate descriptions included 
“rotational allocation” and “using medical history number 
or birthday.” As for dropout, if the number and reasons for 
dropout were described for each subject group, one point 
was assigned. If there was no dropout, that should also be 
described in the main section. In that case, there was nei-
ther an additional point nor a deduction.
2) Allocation concealment: Descriptions of an adequate 
concealment method included descriptions such as 
“non-transparent, sealed bag marked with sequential 
number,” “vessel marked with sequential number,” or 
“randomized allocation controlled by the study center” 
[10].
4. Presentation of the results of the quality assessment
Annual assessment on the basis of the mean total Jadad 
score, ratio of high-quality studies, and adequate conceal-
ment ratio was conducted by grouping the studies in 5-year 
periods because of the small number of RCTs extracted. 
Double-blinding among the items of the Jadad scale analy-
sis was examined except for studies for which double-blind-
ing was impossible. Because a total score of 3 points was 
given for studies for which double-blinding was impossible, 
the total score of 3 points was converted into a total score 
of 5 points for processing.
5. Factors related to the quality of the randomized con-
trolled trials
Three factors associated with the quality of the research 
papers were also examined: first, intervention with a drug 
medication; second, support by a research fund or with in-
terventional products from specific institutions; and third, 
approval of an institutional review board (IRB).     
RESULTS
1. Annual quantitative change in published randomized 
controlled trials 
A total of 28 RCTs were published in the KJU. The papers 
accounted for 0.27% (5 papers) of the journal in the 1990s 
but increased to 1.34% of the journal (23 papers) in the 
2000s (Table 1).
2. Annual qualitative change in published randomized con-
trolled trials
1) Jadad quality assessment scale: The mean Jadad scale 
was 1.67 points during 1991 to 1995, 1.50 points during Korean J Urol 2011;52:642-646
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TABLE 1. Characteristics of RCTs according to publication year
Year Original articles RCTs (%) Jadad scale mean High quality (%)
Adequate allocation 
concealment (%)
1991-1995
1996-2000
2001-2005
2006-2010
   772
1,022
   904
   818
  3 (0.39)
  2 (0.20)
  4 (0.44)
19 (2.32)
1.67
1.50
2.00
1.57
1 (33.3)
0 (0.0)
2 (50.0)
5 (26.3)
0 (0.0)
0 (0.0)
  1 (25.0)
0 (0.0)
Total 3,156 28 (0.80) 1.75 8 (28.6) 1 (3.6)
RCTs: randomized controlled trials
TABLE 2. Domain-specific adequacy of published RCTs as 
assessed by the Jadad scale
Domains
No. of RCTs rated as 
adequate (%)
Randomization
Double-blinding
Reporting of withdrawals
24 (85.7)
11 (61.1)
10 (35.7)
RCTs: randomized controlled trials
TABLE 3. Factors associated with quality of RCTs 
Factors
No. of 
RCTs (%)
Jadad 
scale mean
High 
quality
a (%)
Intervention type
    Drug
    Non-drug
Funding source
    Yes
    No
Review by IRB
    Yes
    No
21
  7
11
17
  6
22
1.86
1.43
2.09
1.53
2.33
1.59
9 (42.9)
2 (28.6)
6 (54.5)
5 (29.4)
5 (83.3)
6 (27.3)
RCTs: randomized controlled trials, IRB: Institutional Review 
Board, 
a: if the total score was 3 points or higher, the study was
assessed as high quality. For studies in which it was impossible 
to perform double-blinding, the study was assessed as high qualify
if the total score was 2 points or higher.
1996 to 2000, and 2.00 points during 2001 to 2005, but de-
creased to 1.57 points during 2006 to 2010. The number of 
the papers assessed as high quality was one paper (20%) 
in the 1990s and seven papers (30.43%) in the 2000s, which 
showed a pattern similar to that for the Jadad scale (Table 
1). 
2) Allocation concealment: Among the RCTs, an appro-
priate concealment method was described in one paper 
(3.6%) and an inappropriate concealment method was de-
scribed in five papers (17.8%). An unclear concealment 
method was described in 22 papers (78.6%), which ac-
counted for the majority of the articles. 
3. Analysis of items on the jadad quality assessment scale
When the three items of the Jadad scale were analyzed in 
the 28 papers, dropout and randomization were described 
in the highest percentage of articles (85.7%). In addition, 
appropriate double-blinding and appropriate reporting of 
withdrawals were described in 11 (61.1%) and 10 (35.7%) 
articles, respectively. The low total score for the quality as-
sessment was mainly attributable to the small number of 
appropriate descriptions of dropout and the lack of dou-
ble-blinding. Among such cases, a total of 10 papers (35.7%) 
were shown to not be eligible for double-blinding. Thus, the 
analysis of the double-blinding item was conducted exclud-
ing those 10 articles (Table 2).  
4. Analysis of factors related to the quality of the articles
During the period of 1980-2010, 21 articles were shown to 
be associated with a drug intervention, and 7 articles were 
associated with nondrug interventions such as procedures 
and surgery. The mean Jadad scale was higher in the pa-
pers associated with a drug intervention than in the papers 
associated with nondrug interventions (1.86 vs 1.43). An 
intervention with a drug was described in nine papers with 
high quality (42.9%), which was also higher than for the 
nondrug interventions. Eleven papers had received ex-
ternal funding, and their mean Jadad scale was 2.09, which 
was higher than the mean value of 1.53 in the unsupported 
papers. High quality (54.5%) was shown in the papers with 
support, and this percentage was higher than in the papers 
without support. IRB approval was described in six papers. 
Their mean Jadad scale was 2.33 (range, 1 to 3), which was 
higher than the mean value for the total RCTs. High quality 
was shown in five papers (83.3%) (Table 3). 
DISCUSSION
There are several quality assessment tools for RCTs, in-
cluding the Campell, Moher, Chalmers, and Jadad meth-
ods, of which the Chalmers and Jadad methods have been 
the most widely used. In the quality assessment of RCTs, 
the suitability of concealment for random allocation, dou-
ble-blinding, and the follow-up rate of subjects are the three 
most important factors [11]. The Jadad scale, which in-
cludes the aforementioned three factors, is a simple and ob-
jective tool that is also used for the quality assessment of 
individual clinical studies for meta-analysis in the 
Cochrane Database of Systematic Review. Accordingly, 
the Jadad method was applied for the quality assessment Korean J Urol 2011;52:642-646
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of RCTs in this study. This is the first report of the quality 
assessment of original articles published in the KJU.
A quality assessment of RCTs published in other jour-
nals in Korea was previously conducted in only two studies. 
Kim et al analyzed 12,760 original articles in five journals 
published in Korea (The Korean Journal of Internal 
Medicine, Journal of the Korean Surgical Society, Korean 
Journal of Obstetrics and Gynecology, Korean Journal of 
Pediatrics, Korean Journal of Family Medicine) [12]. In 
that study, no articles with a total Jadad scale of 4 points 
or higher were found during the period of 1980 to 2000. The 
number of papers with a score of 2 points increased in the 
1990s compared with the 1980s. In addition, the number 
of papers with a score of 3 points increased from two to 
seven. In another study, Chung et al conducted a quality 
assessment of RCTs from 1,290 original articles published 
in the Korean Journal of Family Medicine from 1980 to 
2005 [13]. They reported that RCTs quantitatively in-
creased from 1.09% of the original articles in the 1980s to 
2.63% in the 2000s and that the Jadad scale increased from 
one point in the 1980s to 2.17 points in the 2000s. As for 
quality assessment in urology, Autorino et al extracted 
RCTs from abstracts presented at the World Congress of 
Endourology (WCE) annual meeting during 2004-2006 
and assessed them according to the Consolidated 
Standards for the Reporting of Trials (CONSORT) state-
ment [14]. They reported that RCT was described in the ti-
tle of the abstracts in most cases, that RCTs accounted for 
a small portion of the total abstracts, and that only a small 
number of abstracts satisfied the CONSORT criteria.     
In the present study, prospective RCTs gradually in-
creased quantitatively and qualitatively from KJU volume 
32 in 1991 to volume 51 in 2010. The number of randomized 
clinical studies was 4-fold higher in the 2000s than in the 
1990s, and the papers with high quality also were shown 
to substantially increase. An appropriate concealment 
method was observed in only one paper since 2000. In addi-
tion, no description of dropout and a lack of double-blinding 
were the most common reasons for a low total score. 
Intervention with a drug, support from specific in-
stitutions, and the approval of an IRB were shown to be as-
sociated with the quality of the RCTs. In the case of inter-
vention with a drug, easier conduct of double-blinding by 
use of a placebo could have been possible, and the rate of 
appropriate double-blinding may have been higher be-
cause of the increased number of studies that could perform 
double-blinding. However, the description of appropriate 
randomization and dropout was not high in RCTs with a 
drug intervention, and the reasons for this are unclear. In 
the case of support from specific institutions, a qualitative 
increase was shown to be associated with both a high rate 
of appropriate double-blinding and randomization. This 
result is likely attributable to the fact that it was possible 
to design a large-scale study because of the financial 
support. In addition, two papers approved by an IRB were 
shown to have high quality in most items. Papers approved 
by an IRB are meaningful in that the design and conduct 
of the study are validated during the study planning stage. 
In particular, in the case of RCTs, IRB review is considered 
an international standard. However, such ethical regu-
lations were poorly recognized in Korea in the past. At pres-
ent, because most domestic institutions have an operating 
IRB or have plans to establish an IRB, IRB review is ex-
pected to be helpful for the qualitative improvement of do-
mestic studies.
In foreign studies, when an analysis was conducted on 
articles published in four major journals (British Medical 
Journal, The Journal of the American Medical Association, 
Lancet, New England Journal of Medicine) from January 
2000 to December 2000, 46% were shown to have an in-
appropriate or unclear concealment method  [15], but no 
analysis of the KJU has been reported to date. The KJU, 
which has been indexed in PubMed and PMC, has pub-
lished papers with high quality and is making efforts to be 
registered to SCI(E) [16]. The results of this study can be 
expected to help researchers of the Korean Urological 
Association understand and appropriately conduct dou-
ble-blinding and allocation concealment, which will lead to 
the publication of research papers with improved quality 
in the KJU.
CONCLUSIONS
RCTs published in the KJU have shown both gradual quan-
titative and qualitative growth from 1990 to 2010. 
However, further efforts are required, particularly for ad-
equate double-blinding and allocation concealment meth-
ods, because the growth is insufficient. In addition, more 
attention should be paid to the establishment of more sup-
portive environments and the acquisition of IRB approval 
to improve study quality.  
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